SB
Healthcare & Life Sciences
Surv BioPharma
Surv BioPharma is a Healthcare & Life Sciences startup based in Japan, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Surv BioPharma
Surv BioPharma is a company headquartered in Japan. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Surv BioPharma develops gene therapies using tumor-lytic viruses and targeted drug delivery systems to treat diseases such as malignant bone tumors, aiming to improve efficacy and reduce side effects.
Explore Surv BioPharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.